Finnish VC Maki.vc is set to reach the final close of its second fund at €100 million, the firm is aiming to invest in seed-stage startups across Europe. The new fund has already had a few investments including antigen discovery company Baseimmune and foodtech startup Volare.
“Within the deep tech and brand-driven focus, we have no industry or geographical restrictions, but instead we look for relentless founders. Common to the most advanced technologies and most captivating brands is their ability to approach the world’s greatest challenges in unconventional ways.”
Maki.vc’s founding partner Ilkka Kivimäki
